small molecule

ACYCLOVIR

ACYCLOVIR

Loss of exclusivityloss of exclusivity
CompanyCiplaSee this company's full patent-cliff portfolio

Drug detail

Brand nameACYCLOVIR
Active ingredientACYCLOVIR
Strength5%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalMay 2025
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ACYCLOVIR patent cliff — loss of exclusivity — | CliffBio